Adult

Cansino biologics inc. - Gallery


Gallery


It is currently under evaluation for emergency use listing by the.


Yahoo fait partie de la famille de marques Yahoo.




Number of employees : 1 946 people.

It has similar efficacy to the , another one-shot adenovirus vector vaccine with 66% efficacy in a global trial.





From the only recombinant Ebola vaccine in Asia to the world's first recombinant novel coronavirus vaccine entered clinical study, and China's first and only MCV4 vaccine to the world's first inhaled COVID-19 vaccine candidate, from the establishment of an mRNA technology platform to a number of leading vaccine products in the world, CanSinoBIO has always been at the forefront of vaccine innovation, with a current robust portfolio of 17 vaccines preventing 12 diseases including COVID-19, meningococcal disease and Ebola.



Global Investors 17,414,435 13.





Detailed Description CanSino Biologics Inc.





Global Investors as of 31 Mar 2022 17.



Retrieved 15 February 2022.



It has a collaboration with The National Research Council of Canada to advance vaccine against COVID-19; and co-development agreement with Precision NanoSystems, Inc.




Description: From the only recombinant Ebola vaccine in Asia to the world's first recombinant novel coronavirus vaccine entered clinical study, and China's first and only MCV4 vaccine to the world's first inhaled COVID-19 vaccine candidate, from the establishment of an mRNA technology platform to a number of leading vaccine products in the world, CanSinoBIO has always been at the forefront of vaccine innovation, with a current robust portfolio of 17 vaccines preventing 12 diseases including COVID-19, meningococcal disease and Ebola.

Sexy:
Funny:
Views: 5200 Date: 20.03.2022 Favorited: 181 favorites
Category: DEFAULT

User Comments 3

Post a comment

The new logo retains the original core design by utilizing the DNA double helix structure and remodels it to add texture.
The company has previously collaborated with the NRC on vaccine development.

Hot Categories

Latest Comments

    +126reps
    CanSino Biologics was founded in 2009 in Tianjin by Yu Xuefeng, Zhu Tao, Qiu Dongxu and Helen Mao Huihua. In July 2018, it filed an application to list on the Hong Kong Stock Exchange. It debuted on 28 March 2019 with an increase of 59%, the highest first day trading gain in Hong Kong since 2017.
    By: cheezepoof|||https://www.facebook.com/Gibbles-Cheese-Puffys-62027848355/|||https://twitter.com/cheezepoof17|||https://www.youtube.com/user/Cheezepoof1123
    +381reps
    CanSino Biologics Inc. develops and manufactures biological vaccine products. The Company discovers quadrivalence meningococcal conjugate, pneumococcal polysaccharide, and adenovirus vector-based .
    By: -4d3d3d3-|||https://www.facebook.com/4d3d3d3.engaged|||https://twitter.com/4d3d3d3|||https://www.youtube.com/watch?v=MHWBEK8w_YY
    +229reps
    CanSino Biologics Inc. (CanSinoBIO of the Company) (SSE: , HKEX: 06185) today announced its new brand identity, which is intended to represent the Company's continuous dedication to life.
    By: derphurr|||https://en-gb.facebook.com/public/Hurr-Derr|||https://twitter.com/Berserk_Fan/status/988403783817420801|||https://www.youtube.com/watch?v=Xpolp5alltI
    +322reps
    May 10, 2022 In 2021, the Chinese vaccine company Cansino Biologics Inc. reported an annual operating income of almost two billion yuan, thanks to the sales of Convidecia, CanSino's single-dose .
    By: biccccc|||https://www.facebook.com/Killuashde/|||https://twitter.com/biccccc|||https://www.youtube.com/watch?v=itit-0IT_YM
    +390reps
    Cansino Biologics Inc. focuses on the R&D, production and commercialization of human vaccines. The company provides adenovirus vector vaccine technology, protein structure design and recombination technology, binding technology and preparation technology etc. The company was founded in 2009, headquartered in Tianjin City, China.
    By: Barnes90|||https://en-gb.facebook.com/rory.barnes90|||https://twitter.com/barnes90|||https://www.reddit.com/user/Barnes90
media.punditarena.com - 2022
DISCLAIMER: All models on www.xxxcrowlimg.com adult site are 18 years or older. media.punditarena.com has a zero-tolerance policy against ILLEGAL pornography. All galleries and links are provided by 3rd parties. We have no control over the content of these pages. We take no responsibility for the content on any website which we link to, please use your own discretion while surfing the porn links.
Contact us | Privacy Policy | 18 USC 2257 | DMCA